Authors


Susan Eachus, PhD

Latest:

Effect of Patient Comorbidities on Filling of Antihypertensive Prescriptions

Patients in a Medicaid managed care plan who had cardiovascular comorbidities were not more likely to fill antihypertensive prescriptions than patients without these conditions.


Khaled Nour, MD

Latest:

Cognitive Impairment and Reduced Early Readmissions in Congestive Heart Failure?

Proactive identification of cognitive impairment and compensatory destigmatized patient/familial psychoeducation regarding “forgetfulness” in hospitalized patients with congestive heart failure may reduce readmission rates substantially.


Sally W. Vernon, PhD

Latest:

Utilization of Lymph Node Dissection, Race/Ethnicity, and Breast Cancer Outcomes

The disparities in survival among node-positive breast cancer patients of African American and Hispanic heritage are not explained by nodal surgery utilization.


Nicole Paolini Albanese, PharmD, BCACP, CDE

Latest:

Effect of Changing COPD Triple-Therapy Inhaler Combinations on COPD Symptoms

Changing patients from an inhaled corticosteroid (ICS)/long-acting β agonist (LABA) inhaler and long-acting muscarinic agonist (LAMA) inhaler to a LAMA/LABA inhaler and a separate ICS inhaler did not appear to affect patient-reported chronic obstructive pulmonary disease (COPD) symptom scores.


Daniel Shelden, DO

Latest:

Impact of a Pharmacist-Managed Diabetes Clinic on Quality Measures

This study evaluated a pharmacist-managed diabetes clinic to determine its impact on diabetes-related quality measures.(For Tables and Figures, please access the PDF on last page.)


Yanfang Zhao, MA

Latest:

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting

Pilot testing of guidelines for the laboratory monitoring of high-risk medications shows that monitoring is highly variable and that there is room for improvement.





Laura G. Burke, MD, MPH

Latest:

The Effect of Massachusetts Health Reform on Access to Care for Medicaid Beneficiaries

Although concerns remain that expanding insurance coverage may have a “crowding-out” effect, we saw no evidence of this for Medicaid beneficiaries in Massachusetts following statewide health reform.



Richard Zur, PhD

Latest:

Cost Per Response Analysis of Strategies for Chronic Immune Thrombocytopenia

This decision tree model estimates the cost per response and incremental cost per additional responder for romiplostim, eltrombopag, and “watch and rescue” for immune thrombocytopenia.


David F. Penson, MD, MPH

Latest:

The Influence of Provider Characteristics and Market Forces on Response to Financial Incentives

We determine a specialist physician phenotype responsive to financial incentives that may be leveraged to identify physicians and markets well-suited for participation in alternative payment models.


Timothy J. Atkinson, PharmD, BCPS, CPE

Latest:

Common Elements in Opioid Use Disorder Guidelines for Buprenorphine Prescribing

This article presents a synthesis of opioid use disorder guidelines and a framework to link them to claims data and recognize higher-quality practice, monitor outcomes, and individualize intervention.


Abigail L. Alexander, MS

Latest:

Improving HCV Cure Rates in HIV-Coinfected Patients - A Real-World Perspective

The authors examine real-world hepatitis C virus cure rates with direct-acting antivirals among patients coinfected with HIV.


Alan Lotvin, MD

Latest:

Managing Costs and Enhancing the Value of Oncology Care

Management of high and rising costs in oncology requires a multifaceted approach using both innovative strategies and pragmatic tools. In this article, we discuss several factors that influence the costs of oncology care.


Brian J. Miller, MD, MBA, MPH

Latest:

Comparing Spending Across Medicare Programs

As Medicare Advantage increasingly becomes the dominant form of Medicare coverage, Congress must improve transparency of programmatic costs and benefits to promote beneficiary choice.


Winifred Teuteberg, MD

Latest:

Benchmarking Health-Related Quality-of-Life Data From a Clinical Setting

Health-related quality-of-life data are often collected during routine clinical care. We present a method to create nationally representative benchmarks for clinical subspecialties.


Gene Pellerin, MD

Latest:

Predicting 30-Day Emergency Department Revisits

“Frequent flyers” significantly contribute to emergency department (ED) crowding. This study developed a predictive model that can be used to identify high-risk patients and reduce ED revisits.


James F. Burgess Jr, PhD

Latest:

What Determines Successful Implementation of Inpatient Information Technology Systems?

This paper reports findings from a qualitative analysis of US Department of Veterans Affairs hospitals on factors affecting success in implementing 2 information technology systems.


Alison Jennings, MA

Latest:

Interactive Voice Response Systems for Improving Delivery of Ambulatory Care

A systematic review of interactive voice response system studies showed that these interventions significantly benefit adherence to various processes of care.



Matthew D. Chenoweth, MPH

Latest:

Mapping US Commercial Payers' Coverage Policies for Medical Interventions

The authors examine the largest 20 US commercial payers’ coverage policies and identify variation in how interventions are covered and the evidence reviewed in them.


Justin Simoncini, MBA, MPH

Latest:

CAR-T Cells: The Next Era in Immuno-Oncology

An update on immunotherapies and the potential impact of chimeric antigen receptor (CAR)-T cells on oncology care.



Pan Wu, PhD

Latest:

Using Aggregated Pharmacy Claims to Identify Primary Nonadherence

We used aggregated pharmacy claims data available within the electronic health record to identify a high rate of primary nonadherence in a nonintegrated primary care network.


Suh-May Yen, MD, PhD

Latest:

Factors Related to Continuing Care and Interruption of P4P Program Participation in Patients With Diabetes

Analyzing factors associated with continuing care participation in patients with diabetes and with interrupted participation by patients enrolled in a diabetes pay-for-performance program.



the members of the Joslin Guidelines Committee

Latest:

CHAPTER 4. Guideline for the Care of the Older Adult With Diabetes

From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts. This guideline was revised and approved May 17, 2017, and updated February 7, 2018.


Valentina Orlando, PharmD

Latest:

Assessment and Potential Determinants of Compliance and Persistence to Antiosteoporosis Therapy in Italy

This analysis of antiosteoporosis therapy shows that 75% of patients have inadequate drug coverage and that adherence is strongly associated with age and administration regimen.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo